Literature DB >> 25186894

Cell biology: A guardian angel of cell integrity.

Francis Ka-Ming Chan1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25186894     DOI: 10.1038/513038a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  Death by design: apoptosis, necrosis and autophagy.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Curr Opin Cell Biol       Date:  2004-12       Impact factor: 8.382

2.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

3.  RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.

Authors:  A T Ting; F X Pimentel-Muiños; B Seed
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

4.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

5.  RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

Authors:  James A Rickard; Joanne A O'Donnell; Joseph M Evans; Najoua Lalaoui; Ashleigh R Poh; TeWhiti Rogers; James E Vince; Kate E Lawlor; Robert L Ninnis; Holly Anderton; Cathrine Hall; Sukhdeep K Spall; Toby J Phesse; Helen E Abud; Louise H Cengia; Jason Corbin; Sandra Mifsud; Ladina Di Rago; Donald Metcalf; Matthias Ernst; Grant Dewson; Andrew W Roberts; Warren S Alexander; James M Murphy; Paul G Ekert; Seth L Masters; David L Vaux; Ben A Croker; Motti Gerlic; John Silke
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

6.  RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.

Authors:  Christopher P Dillon; Ricardo Weinlich; Diego A Rodriguez; James G Cripps; Giovanni Quarato; Prajwal Gurung; Katherine C Verbist; Taylor L Brewer; Fabien Llambi; Yi-Nan Gong; Laura J Janke; Michelle A Kelliher; Thirumala-Devi Kanneganti; Douglas R Green
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

Review 7.  RIP3: a molecular switch for necrosis and inflammation.

Authors:  Kenta Moriwaki; Francis Ka-Ming Chan
Journal:  Genes Dev       Date:  2013-08-01       Impact factor: 11.361

8.  A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.

Authors:  Francis Ka-Ming Chan; Joanna Shisler; Jacqueline G Bixby; Martin Felices; Lixin Zheng; Michael Appel; Jan Orenstein; Bernard Moss; Michael J Lenardo
Journal:  J Biol Chem       Date:  2003-10-07       Impact factor: 5.157

9.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

Review 10.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

View more
  1 in total

1.  Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins.

Authors:  Poonam Tewary; Alan D Brooks; Ya-Ming Xu; E M Kithsiri Wijeratne; Ashley L Babyak; Timothy C Back; Raj Chari; Christine N Evans; Curtis J Henrich; Thomas J Meyer; Elijah F Edmondson; Maria T Prudente de Aquino; Thanigaivelan Kanagasabai; Anil Shanker; A A Leslie Gunatilaka; Thomas J Sayers
Journal:  Cancer Res       Date:  2021-04-09       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.